According to Vitrolife AB's latest financial reports the company's current EPS (TTM) is 0,30 โฌ. In 2023 the company made an earnings per share (EPS) of -2,52 โฌ a decrease over its 2022 EPS that were of 0,25 โฌ.
Year | EPS | Change |
---|---|---|
2024 (TTM) | 0,31 โฌ | -112.35% |
2023 | -2,52 โฌ | -1109.12% |
2022 | 0,25 โฌ | -14.75% |
2021 | 0,29 โฌ | 1.83% |
2020 | 0,29 โฌ | -14.66% |
2019 | 0,34 โฌ | 19.03% |
2018 | 0,28 โฌ | 6.83% |
2017 | 0,27 โฌ | 53.82% |
2016 | 0,17 โฌ | -3.56% |
2015 | 0,18 โฌ | 42.16% |
2014 | 0,13 โฌ | 58.99% |
2013 | 0,07907 โฌ | -83.1% |
2012 | 0,47 โฌ | 1062.75% |
2011 | 0,04024 โฌ | 2.77% |
2010 | 0,03915 โฌ | -11.28% |
2009 | 0,04413 โฌ | 27.36% |
2008 | 0,03465 โฌ | -31.11% |
2007 | 0,05030 โฌ | 150.37% |
2006 | 0,02009 โฌ | 10.6% |
2005 | 0,01816 โฌ | -2.04% |
2004 | 0,01854 โฌ | -69.22% |
2003 | 0,06024 โฌ | -53.67% |
2002 | 0,13 โฌ |